The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
To clarify the role that the src homology 2-containing inositol phosphatase (SHIP) plays in mast cell degranulation, the gene for SHIP was disrupted by homologous recombination in embryonic stem cells. Bone-marrow-derived mast cells from SHIP+/+, +/−, and −/− F 2 littermates were compared. SHIP−/− mast cells were found to be far more prone to degranulation, after the crosslinking of IgE preloaded cells, than SHIP+/− or +/+ cells. Intriguingly, IgE alone also stimulated massive degranulation in SHIP−/− but not in +/+ mast cells. This degranulation with IgE alone, which may be due to low levels of IgE aggregates, correlated with a higher and more sustained intracellular calcium level than that observed with SHIP+/+ cells and was dependent upon the entry of extracellular calcium. Immunoprecipitation studies revealed that the addition of IgE alone to normal mast cells stimulates multiple cascades, which are prevented from progressing to degranulation by SHIP. PI 3-kinase inhibitor studies suggested that IgE-induced activation of PI 3-kinase is upstream of the entry of extracellular calcium and that SHIP restricts this entry by hydrolyzing phosphatidylinositol 3,4,5-trisphosphate. These results show the critical role that SHIP plays in setting the threshold for degranulation and that SHIP directly modulates a “positive-acting” receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ono, M., Bolland, S., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 781
Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., & Matsuda, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74466-4 · Cited by 725
Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W., & Krystal, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1689 · Cited by 633
Self-citationHelgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G., & Humphries, R. K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1610 · Cited by 556
Self-citationDeletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling
Ono, M., Okada, H., Bolland, S., Yanagi, S., Kurosaki, T., & Ravetch, J. V. (1997) · Cell · doi:10.1016/s0092-8674(00)80337-2 · Cited by 499
Yamaguchi, M., Lantz, C. S., Oettgen, H. C., Katona, I. M., Fleming, T., Miyajima, I., Kinet, J.-P., & Galli, S. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.663 · Cited by 448
Scharenberg, A. M., El-Hillal, O., Fruman, D. A., Beitz, L. O., Li, Z., Lin, S., Gout, I., Cantley, L. C., Rawlings, D. J., & Kinet, J.-P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.1961 · Cited by 429
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A., & Rohrschneider, L. R. (1996) · Genes & Development · doi:10.1101/gad.10.9.1084 · Cited by 418
Fluckiger, A.-C., Li, Z., Kato, R. M., Wahl, M. I., Ochs, H. D., Longnecker, R., Kinet, J.-P., Witte, O. N., Scharenberg, A. M., & Rawlings, D. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.1973 · Cited by 402
Zhang, J., Berenstein, E. H., Evans, R. L., & Siraganian, R. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.71 · Cited by 262
Cited by
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141025 · Cited by 1,017
Regulation of mast-cell and basophil function and survival by IgE
Kawakami, T., & Galli, S. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri914 · Cited by 633
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 598
The role of the mast cell in the pathophysiology of asthma
Bradding, P., Walls, A. F., & Holgate, S. T. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.039 · Cited by 573
The role of PI3K in immune cells
Koyasu, S. (2003) · Nature Immunology · doi:10.1038/ni0403-313 · Cited by 487
Molecular regulation of mast cell activation
Rivera, J., & Gilfillan, A. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.015 · Cited by 459
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation
Parravicini, V., Gadina, M., Kovarova, M., Odom, S., Gonzalez-Espinosa, C., Furumoto, Y., Saitoh, S., Samelson, L. E., O'Shea, J. J., & Rivera, J. (2002) · Nature Immunology · doi:10.1038/ni817 · Cited by 448
The tyrosine kinase network regulating mast cell activation
Gilfillan, A. M., & Rivera, J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00742.x · Cited by 428
Kalesnikoff, J., Huber, M., Lam, V., Damen, J. E., Zhang, J., Siraganian, R. P., & Krystal, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00159-5 · Cited by 412
Self-citationLiu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
“It has been identified as a crucial negative regulator of B-cell activation (Ono et al. 1997; Liu et al. 1998a) and IgE-mediated mast cell degranulation (Huber et al. 1998).”
BackgroundLPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., & Krystal, G. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.010 · Cited by 306
Self-citationStructure, function, and biology of SHIP proteins
Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., & Lucas, D. M. (2000) · Genes & Development · doi:10.1101/gad.14.5.505 · Cited by 294
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function
Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E., & Wymann, M. P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00282-0 · Cited by 286
Mammalian phosphoinositide kinases and phosphatases
Sasaki, T., Takasuga, S., Sasaki, J., Kofuji, S., Eguchi, S., Yamazaki, M., & Suzuki, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.06.001 · Cited by 283
Physical Exercise Inhibits Inflammation and Microglial Activation
Mee-inta, O., Zhao, Z.-W., & Kuo, Y.-M. (2019) · Cells · doi:10.3390/cells8070691 · Cited by 268
TLR signaling in mast cells: common and unique features
Sandig, H., & Bulfone-Paus, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00185 · Cited by 268
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 252
Self-citationThe SH2 domain: versatile signaling module and pharmaceutical target
Machida, K., & Mayer, B. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.005 · Cited by 206
Signal Transduction by the High-Affinity Immunoglobulin E Receptor FcεRI: Coupling Form to Function
Nadler, M. J. S., Matthews, S. A., Turner, H., & Kinet, J.-P. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76022-1 · Cited by 203
Ujike, A., Ishikawa, Y., Ono, M., Yuasa, T., Yoshino, T., Fukumoto, M., Ravetch, J. V., & Takai, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1573 · Cited by 182
“Mast cells derived from SHIP-deficient mice display a hyperresponsive IgE phenotype similar to the response seen in FcgRIIB2/2 mice ( 26 ).”
BackgroundChapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE
Rivera, J., Fierro, N. A., Olivera, A., & Suzuki, R. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00403-3 · Cited by 180
Function, regulation and pathological roles of the Gab/DOS docking proteins
Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-22 · Cited by 171
Cox, D., Dale, B. M., Kashiwada, M., Helgason, C. D., & Greenberg, S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.61 · Cited by 158
Self-citationPossible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
Huang, Z.-Y., Hunter, S., Kim, M.-K., Indik, Z. K., & Schreiber, A. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902454 · Cited by 105
GPCR activation of Ras and PI3Kγ in neutrophils depends on PLCβ2/β3 and the RasGEF RasGRP4
Suire, S., Lécureuil, C., Anderson, K. E., Damoulakis, G., Niewczas, I., Davidson, K., Guillou, H., Pan, D., Clark, J., Hawkins, P. T., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.167 · Cited by 77
“Many receptors are capable of simultaneously activating PLCs and class I PI3Ks and in some cells (e.g., B cells and mast cells) activation of PLC g s can depend on class I PI3K signalling (Huber et al , 1998; Scharenberg et al , 1998).”
Pérez-Baena, M. J., Cordero-Pérez, F. J., Pérez-Losada, J., & Holgado-Madruga, M. (2023) · Cancers · doi:10.3390/cancers15164179 · Cited by 25
“Since the PH domain of GAB1 is involved in the interaction with PIP3 present in biological membranes and these are products of PI3K kinase action, it has been reported that the lipid phosphatase and tensin homologue (PTEN) or SH2 domain-containing inositol 5-phosphatases 1/2 (SHIP1/2) could negatively influence the GA…”
BackgroundThe SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: Impact on SHIP1/Ig-α interaction
Mukherjee, O., Weingarten, L., Padberg, I., Pracht, C., Sinha, R., Hochdörfer, T., Kuppig, S., Backofen, R., Reth, M., & Huber, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.019 · Cited by 20
Self-citationImmunologic characterization of 3 murine regimens of allergen-specific immunotherapy
Fox, E. M., Torrero, M. N., Evans, H., & Mitre, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.052 · Cited by 15
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Yeoh, W. J., & Krebs, P. (2023) · European Journal of Immunology · doi:10.1002/eji.202350446 · Cited by 14
Metadata
- Authors
- Huber, M., Helgason, C. D., Damen, J. E., Liu, L., Humphries, R. K., & Krystal, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-09-15
- Volume
- 95
- Issue
- 19
- Pages
- 11330-11335
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2154161087
- Cited by
- 316
- References
- 31
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.